论文部分内容阅读
目的:分析肾移植术后肺部并发症患者的临床特征,并探讨临床防治方法。方法:对郑州市第七人民医院2016年1月至2016年12月收治的实施肾移植手术治疗的70例患者的临床资料展开回顾性调查与分析,统计其临床特征分布情况,并探讨防治方法及预后。结果:所有患者中肺部并发症发生率为20.00%,其中肺部感染、急性肺水肿和坠积性肺炎的构成比分别为10.00%、2.86%和7.14%;出现肺部并发症患者中出现肺部并发症患者中男性、年龄>60岁、心脏死亡器官捐献(DCD)的构成比分别为70.00%、60.00%、85.00%,肺部感染常见的病原微生物有卡氏肺孢子、巨细胞病毒、真菌,使用免疫抑制剂、使用糖皮质激素、尿毒症、长期卧床等均是肺部感染的常见病因,移植肾功能延迟恢复(DGF)和急性排斥反应是急性肺水肿的常见病因;出现肺部并发症的患者死亡率为14.29%。结论:肾移植术后肺部并发症的风险较高,且发病原因较多,死亡率高,需要及时给予有效的防治措施才能降低并发症风险,改善患者的预后。
Objective: To analyze the clinical characteristics of patients with pulmonary complications after renal transplantation and to explore the clinical prevention and treatment methods. Methods: The clinical data of 70 patients who underwent renal transplantation from January 2016 to December 2016 in Zhengzhou Seventh People’s Hospital were retrospectively investigated and analyzed. The distribution of clinical features was analyzed and the methods of prevention and treatment were also discussed And prognosis. Results: The incidence of pulmonary complications in all patients was 20.00%, of which the constituent ratios of pulmonary infection, acute pulmonary edema and hypostatic pneumonia were 10.00%, 2.86% and 7.14% respectively. The occurrence of pulmonary complications Among the patients with pulmonary complications, the male patients aged> 60 years and the constituent ratios of cardiac death organ donation (DCD) were 70.00%, 60.00% and 85.00% respectively. The common pathogenic microorganisms of pulmonary infection were Pneumocystis carinii, Cytomegalovirus , Fungi, the use of immunosuppressive agents, the use of glucocorticoid, uremia, prolonged bed rest are common causes of lung infections, delayed graft function and acute rejection (acute rejection) is a common cause of acute pulmonary edema; Department of complications in patients with mortality was 14.29%. Conclusion: The risk of pulmonary complications after renal transplantation is high, and the causes of the disease are high and the mortality rate is high. Effective prevention and treatment measures should be given in time to reduce the risk of complications and improve the prognosis of patients.